Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlo Heirman

Showing results (71-80 of 80) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 80 results.
Journal of Immunology (Baltimore, Md. : 1950)|November 5, 2008
Dendritic cells genetically engineered to express IL-10 induce long-lasting antigen-specific tolerance in experimental asthmaEmmanuelle Henry, Christophe J Desmet, Virginie Garzé, et al.
Melanoma Research|August 27, 2009
Hemorrhagic regression of melanoma metastases during therapeutic vaccination: a report of three casesLauranne Pierret, Nicolas Van Baren, Aude Bonehill, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 28, 2011
Sirtuin 1 promotes Th2 responses and airway allergy by repressing peroxisome proliferator-activated receptor-γ activity in dendritic cellsAgnieszka Legutko, Thomas Marichal, Laurence Fiévez, et al.
Oncotarget|September 24, 2016
The tumor-associated antigen RHAMM (HMMR/CD168) is expressed by monocyte-derived dendritic cells and presented to T cellsYannick Willemen, Johan M J Van den Bergh, Sarah M Bonte, et al.
Cancer Research|December 21, 2017
Loss of RASSF4 Expression in Multiple Myeloma Promotes RAS-Driven Malignant ProgressionEva De Smedt, Ken Maes, Stefaan Verhulst, et al.
International Journal of Cancer|February 6, 2019
GITR ligation enhances functionality of tumor-infiltrating T cells in hepatocellular carcinomaAdriaan A van Beek, Guoying Zhou, Michail Doukas, et al.
AIDS (London, England)|October 6, 2018
Phase I clinical trial of an intranodally administered mRNA-based therapeutic vaccine against HIV-1 infectionLorna Leal, Alberto C Guardo, Sara Morón-López, et al.
ACS Nano|September 27, 2018
Dendritic Cell Targeting mRNA Lipopolyplexes Combine Strong Antitumor T-Cell Immunity with Improved Inflammatory SafetyKevin Van der Jeught, Stefaan De Koker, Lukasz Bialkowski, et al.
Clinical Immunology (Orlando, Fla.)|December 20, 2011
A phase I/IIa immunotherapy trial of HIV-1-infected patients with Tat, Rev and Nef expressing dendritic cells followed by treatment interruptionSabine D Allard, Brenda De Keersmaecker, Anna L de Goede, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 6, 2026
Autoantigen mRNA-LNP Vaccination Drives Therapeutic Efficacy in Preclinical Models for AutoimmunityPaulien Baeten, Karen Beets, Tessa Schalley, et al.
Pageof 8

Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
Journal of Immunology (Baltimore, Md. : 1950)|November 5, 2008
Dendritic cells genetically engineered to express IL-10 induce long-lasting antigen-specific tolerance in experimental asthmaEmmanuelle Henry, Christophe J Desmet, Virginie Garzé, et al.
Melanoma Research|August 27, 2009
Hemorrhagic regression of melanoma metastases during therapeutic vaccination: a report of three casesLauranne Pierret, Nicolas Van Baren, Aude Bonehill, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 28, 2011
Sirtuin 1 promotes Th2 responses and airway allergy by repressing peroxisome proliferator-activated receptor-γ activity in dendritic cellsAgnieszka Legutko, Thomas Marichal, Laurence Fiévez, et al.
Oncotarget|September 24, 2016
The tumor-associated antigen RHAMM (HMMR/CD168) is expressed by monocyte-derived dendritic cells and presented to T cellsYannick Willemen, Johan M J Van den Bergh, Sarah M Bonte, et al.
Cancer Research|December 21, 2017
Loss of RASSF4 Expression in Multiple Myeloma Promotes RAS-Driven Malignant ProgressionEva De Smedt, Ken Maes, Stefaan Verhulst, et al.
International Journal of Cancer|February 6, 2019
GITR ligation enhances functionality of tumor-infiltrating T cells in hepatocellular carcinomaAdriaan A van Beek, Guoying Zhou, Michail Doukas, et al.
AIDS (London, England)|October 6, 2018
Phase I clinical trial of an intranodally administered mRNA-based therapeutic vaccine against HIV-1 infectionLorna Leal, Alberto C Guardo, Sara Morón-López, et al.
ACS Nano|September 27, 2018
Dendritic Cell Targeting mRNA Lipopolyplexes Combine Strong Antitumor T-Cell Immunity with Improved Inflammatory SafetyKevin Van der Jeught, Stefaan De Koker, Lukasz Bialkowski, et al.
Clinical Immunology (Orlando, Fla.)|December 20, 2011
A phase I/IIa immunotherapy trial of HIV-1-infected patients with Tat, Rev and Nef expressing dendritic cells followed by treatment interruptionSabine D Allard, Brenda De Keersmaecker, Anna L de Goede, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 6, 2026
Autoantigen mRNA-LNP Vaccination Drives Therapeutic Efficacy in Preclinical Models for AutoimmunityPaulien Baeten, Karen Beets, Tessa Schalley, et al.
Pageof 8